Short Interest in Henry Schein, Inc. (HSIC) Increases By 47.2%
Henry Schein, Inc. (NASDAQ:HSIC) saw a significant growth in short interest in the month of September. As of September 29th, there was short interest totalling 8,187,143 shares, a growth of 47.2% from the September 15th total of 5,562,584 shares. Based on an average daily trading volume, of 1,754,214 shares, the days-to-cover ratio is currently 4.7 days. Currently, 5.3% of the company’s shares are short sold.
In related news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the transaction, the senior vice president now owns 17,841 shares in the company, valued at $3,077,750.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.27% of the stock is owned by insiders.
Several institutional investors have recently modified their holdings of HSIC. YorkBridge Wealth Partners LLC boosted its stake in Henry Schein by 5.2% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after purchasing an additional 28 shares in the last quarter. Sun Life Financial INC boosted its stake in Henry Schein by 8,185.7% in the 2nd quarter. Sun Life Financial INC now owns 580 shares of the company’s stock worth $106,000 after purchasing an additional 573 shares in the last quarter. Lee Financial Co acquired a new stake in Henry Schein in the 2nd quarter worth approximately $161,000. Acrospire Investment Management LLC boosted its stake in Henry Schein by 150.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock worth $183,000 after purchasing an additional 600 shares in the last quarter. Finally, Van ECK Associates Corp boosted its stake in Henry Schein by 5.7% in the 1st quarter. Van ECK Associates Corp now owns 1,138 shares of the company’s stock worth $193,000 after purchasing an additional 61 shares in the last quarter. 44.56% of the stock is currently owned by hedge funds and other institutional investors.
Henry Schein (HSIC) opened at 80.67 on Thursday. Henry Schein has a 52 week low of $73.11 and a 52 week high of $93.50. The stock has a 50 day moving average of $83.08 and a 200 day moving average of $87.43. The company has a market cap of $12.75 billion, a P/E ratio of 23.57 and a beta of 1.08.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, August 8th. The company reported $0.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.86 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm had revenue of $3.06 billion for the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter in the previous year, the firm earned $0.82 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, analysts expect that Henry Schein will post $3.64 earnings per share for the current year.
Henry Schein declared that its Board of Directors has initiated a share repurchase program on Monday, September 18th that permits the company to repurchase $400.00 million in outstanding shares. This repurchase authorization permits the company to reacquire up to 6.3% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s leadership believes its shares are undervalued.
Several brokerages recently issued reports on HSIC. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Northcoast Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price objective on the stock in a research note on Monday, August 7th. BidaskClub lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. Jefferies Group LLC reissued a “hold” rating and set a $88.50 price objective on shares of Henry Schein in a research note on Thursday, September 28th. Finally, Credit Suisse Group reissued a “hold” rating and set a $80.00 price objective on shares of Henry Schein in a research note on Thursday, July 13th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and six have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $92.14.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/10/12/short-interest-in-henry-schein-inc-hsic-increases-by-47-2.html.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.